Acne Variants
Acne is not limited to the common form (acne vulgaris). In practice, dermatologists regularly see special acne variants — distinct conditions with unusual clinical features and a complicated course. They are often linked to severe systemic immune reactions, psychological and behavioral disorders, or significant external triggers such as oral medications, cosmetics and harmful chemicals.
How Haute-Derma Manages Acne Variants
Because these variants can progress quickly and leave severe scarring, Haute-Derma follows strict treatment principles:
- Control systemic inflammation before treating pigmentation and scars: in fulminant or severe nodulocystic acne, the first priority is to bring the necrotizing inflammation under control with medical treatment. Scar lasers and peels are never rushed in at this stage.
- Remove external causes: acne-triggering agents are identified and stopped right away (topical or oral corticosteroids, cosmetics with heavy mineral oils, or systemic drugs that can be substituted).
- Address behavior alongside the skin: for self-picking acne (acne excoriée), psychological support and behavioral education help patients manage anxiety before any cosmetic procedure.
Screening and Clinical Classification at Haute-Derma
- Assessing systemic inflammation: we check vital signs (fever) and bone or joint pain (especially at the sternoclavicular joint), and order a complete blood count (looking for neutrophilia) and erythrocyte sedimentation rate (ESR) to identify acne fulminans early.
- Direct microscopy to rule out Malassezia folliculitis: this is common in patients who break out suddenly after long courses of corticosteroids or oral antibiotics. Telling drug-induced acne apart from yeast folliculitis prevents prescribing errors.
- Medication and product history: we list every medication the patient takes (corticosteroids, lithium, anti-tuberculosis drugs, antiepileptics, EGFR-targeted cancer therapies) and every topical product used in the past 6 months.
Clinical Management and Aesthetic Treatment at Haute-Derma
Our treatment strategy aims to switch off the follicular immune reaction, protect the basement membrane and rebuild the dermal matrix:
- Combined medical treatment (for acne fulminans and acne conglobata):
- Moderate-dose oral corticosteroids (0.5–1.0 mg/kg/day): a short course to rapidly suppress the necrotizing follicular inflammation and stop ulceration from spreading.
- Very low-dose isotretinoin (0.1 mg/kg/day): started only after 2–4 weeks of corticosteroids have brought the acute inflammation under control, so the sebaceous glands shrink gradually without provoking a second flare.
- Long-pulsed Nd:YAG laser (1064 nm): used at low energy with millisecond pulses to target the small vessels feeding deep nodulocystic lesions (acne conglobata). Controlled heating shrinks draining sinus tracts under the skin, kills anaerobic bacteria and stimulates healthy collagen production to fill in necrotic cavities.
- Cold electroporation to restore the epidermal lipid barrier: a combination of reparative actives — beta-glucan, pure madecassoside 95% and panthenol (vitamin B5) — calms skin that is irritated and peeling from topical steroid overuse or drug-induced acne.
- Gentle home-care protocol:
- Azelaic acid 15–20%: an ideal choice thanks to its strong anti-inflammatory and antibacterial effects, without the irritation or barrier damage that high-strength BHA or benzoyl peroxide can cause.
- Non-foaming cleanser: pH 5.5 with skin-identical ceramides to preserve the protective lipid layer throughout treatment.